Vivid Bioinnovations, PBC
San Francisco, CA
- UEI
- Q1NZN4P95F83
- CAGE
- 8BMG6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 953 Indiana St, San Francisco, CA 94107, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Spatially resolved single-cell DNA sequencing: a general spatial genomics platform with application to HIV reservoir… | National Institute of Allergy and Infectious Diseases | $299,991 | |
| Hive-SEQ: a novel omics technology to profile thousands of single HIV-positive cells - abstract identifying and fully… | National Institute of Allergy and Infectious Diseases | $307,074 | |
| Ultrahigh-throughput cell interaction screening to advance car-t therapeutic development - abstract chimeric antigen… | National Cancer Institute | $306,872 | |
| Integrated high-throughput microfluidic-mass spectrometry for enhanced biomedical data generation and AI model… | National Institute of General Medical Sciences | $300,001 | |
| Find-SEQ: a novel cell sorting technology to enable investigation of rare cells in primary human tissues - abstract rare… | National Institute on Aging | $1,626,390 |
About Vivid Bioinnovations, PBC
Fluid Discovery, Inc. is a San Francisco-based for-profit corporate entity specializing in advanced microfluidic and biotechnology innovations, focusing on developing cutting-edge technologies for scientific research and diagnostics. Registered in SAM.gov since May 2019, the company operates at the intersection of microfluidics, biophysics, and genomics, creating novel platforms for cell sorting, enzyme engineering, and diagnostic technologies. The company appears to be a technology development firm that leverages precision fluid handling and advanced computational techniques to create transformative solutions for biomedical research, particularly in areas like HIV diagnostics, neurodegenerative disease research, and biocatalyst evolution.
Through its federal contract awards, Fluid Discovery, Inc. has demonstrated capabilities in developing specialized diagnostic technologies, specifically working with the Department of Health and Human Services' National Institutes of Health. The company was awarded a Small Business Innovation Research (SBIR) Phase I contract from the National Institute of Allergy and Infectious Diseases to develop "Multiplexed Droplet Digital Nucleic Acid Amplification Technologies for HIV Diagnosis," a $299,903 firm-fixed-price contract set aside for small businesses. This contract highlights the company's expertise in creating advanced diagnostic technologies for infectious disease research, with a specific focus on developing innovative methods for HIV diagnosis.
Fluid Discovery, Inc. has secured multiple federal grant awards from various National Institutes of Health agencies, focusing on groundbreaking research and technological development. These grants span diverse areas including a $306,871 grant from the National Institute on Aging to develop FIND-SEQ, a novel cell sorting technology for isolating rare cells; a $306,872 grant from the National Institute of General Medical Sciences for developing an ultrahigh-throughput biocatalyst evolution platform; and additional grants targeting point-of-care viral load monitoring for HIV research and single-cell tri-omics profiling. The company's grant-funded projects consistently demonstrate sophisticated technological approaches to challenging scientific problems, leveraging advanced microfluidics, mass spectrometry, and computational techniques to drive innovation in biotechnology, genomics, and medical diagnostics.
Quick answers
What is Vivid Bioinnovations, PBC's UEI?
Vivid Bioinnovations, PBC's Unique Entity ID (UEI) in SAM.gov is Q1NZN4P95F83.
What is Vivid Bioinnovations, PBC's CAGE code?
Vivid Bioinnovations, PBC's CAGE code is 8BMG6.
What is Vivid Bioinnovations, PBC's primary NAICS code?
Vivid Bioinnovations, PBC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Vivid Bioinnovations, PBC located?
Vivid Bioinnovations, PBC's physical address in SAM.gov is 953 Indiana St, San Francisco, CA 94107, USA.
Is Vivid Bioinnovations, PBC registered in SAM.gov?
Yes. Vivid Bioinnovations, PBC's SAM.gov registration is active through July 27, 2027.
What is Vivid Bioinnovations, PBC's most recent federal award?
Vivid Bioinnovations, PBC's most recent federal grant award is Spatially resolved single-cell DNA sequencing: a general spatial genomics platform with application to HIV reservoir… (R44AI197850), from National Institute of Allergy and Infectious Diseases, on September 1, 2026.
On GovTribe
See Vivid Bioinnovations, PBC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors